Skip to main content
  • Fracturing Bioprosthetic THVs Shows Increased Mortality Risk, ‘Modest’ Hemodynamic Benefit, in ViV TAVR – Analysis

    BOSTON — Fracturing balloon-expandable bioprosthetic transcatheter heart valves (THVs) was associated with an early risk of in-hospital mortality, especially when performed before valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR), a new registry analysis shows.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details